Management of oropharyngeal squamous cell carcinoma.
Cancer Radiother
; 26(1-2): 174-188, 2022.
Article
in En
| MEDLINE
| ID: mdl-34953693
ABSTRACT
This article reviews the various treatment options, by primary or postoperative external radiotherapy and by brachytherapy for the p16-negative oropharyngeal squamous cell carcinoma. Dose levels, fractionation and association with systemic treatments are presented. The need for neck node dissection post local treatment is discussed, as well as specificities for the management of p16-positive tumours. Guidelines for target volume selection and delineation are thoroughly elaborated. Last, the management by radiotherapy of locoregional recurrences is discussed.
Key words
Brachytherapy; Chimioradiothérapie concomitante; Concomitant chemoradiotherapy; Curiethérapie; French society for radiation oncology; Guidelines; Oropharyngeal tumours; P16-positive tumor; Radiation therapy; Radiothérapie; Recommandations; Société française de radiothérapie oncologique; Tumeur de l'oropharynx; Tumeur p16-positive; VMAT
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Oropharyngeal Neoplasms
/
Squamous Cell Carcinoma of Head and Neck
Type of study:
Guideline
Limits:
Humans
Country/Region as subject:
Europa
Language:
En
Journal:
Cancer Radiother
Journal subject:
NEOPLASIAS
/
RADIOTERAPIA
Year:
2022
Document type:
Article